Abstract
The immune system plays an essential role in the pathogenesis, prevention and treatment of infectious diseases. Immunoinfectomics is an emerging field that addresses the interface between the host immune system and pathogens, and studies immunomes and infectomes (immunoinfectomes). Immune responses induced by microbial infections are complex phenomena that supervene on the levels of genomes, and as a result, infection and immunity ultimately depend on immunoinfectomes. The computational and mathematical approaches have shown practical benefits to convert all these complex data into sophisticated computer models of cellular gene and protein networks. The availability of the above methods has resulted in exciting new progress in the discovery and development of drugs and vaccines against infectious diseases with immunoinfectomic approaches. It has been demonstrated that only one single variable domain antibody fragment, referred to as VHH (variable heavy chain antibody) or nanobody, can interact with antigens. Nanobodies display several characteristics superior to the conventional antibodies, including their non-immunogenicity and high thermal and chemical stability. These characteristics make nanobodies strong candidates as targeting agents for infectious diseases. Recently, tremendous progress has been made in immune epitope mapping and vaccine candidate identification through the use of the immunoinfectomic approaches. These omic approaches provide powerful tools for advances in system biology of microbial infections and the discovery of novel antimicrobial agents.
Keywords: Alarmins, epitope, immunomes, infectomes, immunoinfectomes, nanobody, vaccine.
Anti-Infective Agents
Title:Exploring Novel Immunological Interventions Using Immunoinfectomics
Volume: 11 Issue: 2
Author(s): Qiqi Zhu, Lin Wang, Suoqin Tang, Hong Cao and Sheng-He Huang
Affiliation:
Keywords: Alarmins, epitope, immunomes, infectomes, immunoinfectomes, nanobody, vaccine.
Abstract: The immune system plays an essential role in the pathogenesis, prevention and treatment of infectious diseases. Immunoinfectomics is an emerging field that addresses the interface between the host immune system and pathogens, and studies immunomes and infectomes (immunoinfectomes). Immune responses induced by microbial infections are complex phenomena that supervene on the levels of genomes, and as a result, infection and immunity ultimately depend on immunoinfectomes. The computational and mathematical approaches have shown practical benefits to convert all these complex data into sophisticated computer models of cellular gene and protein networks. The availability of the above methods has resulted in exciting new progress in the discovery and development of drugs and vaccines against infectious diseases with immunoinfectomic approaches. It has been demonstrated that only one single variable domain antibody fragment, referred to as VHH (variable heavy chain antibody) or nanobody, can interact with antigens. Nanobodies display several characteristics superior to the conventional antibodies, including their non-immunogenicity and high thermal and chemical stability. These characteristics make nanobodies strong candidates as targeting agents for infectious diseases. Recently, tremendous progress has been made in immune epitope mapping and vaccine candidate identification through the use of the immunoinfectomic approaches. These omic approaches provide powerful tools for advances in system biology of microbial infections and the discovery of novel antimicrobial agents.
Export Options
About this article
Cite this article as:
Zhu Qiqi, Wang Lin, Tang Suoqin, Cao Hong and Huang Sheng-He, Exploring Novel Immunological Interventions Using Immunoinfectomics, Anti-Infective Agents 2013; 11 (2) . https://dx.doi.org/10.2174/2211352511311020004
DOI https://dx.doi.org/10.2174/2211352511311020004 |
Print ISSN 2211-3525 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-3533 |
Call for Papers in Thematic Issues
An Overview of Drugs for Multiple Targets and Variants of SARS-CoV-2 Through Artificial Intelligence, Machine Learning, Deep Learning, and Experimental Analysis
The emergence and rapid evolution of SARS-CoV-2 variants have posed significant challenges in the ongoing fight against the COVID-19 pandemic. The development of effective treatments for multiple viral targets and variants demands innovative approaches, including artificial intelligence (AI), machine learning (ML), and deep learning (DL) techniques. This special issue aims ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
New Insights about the Potential Application of the Association of Vitamins C (Sodium Ascorbate) and K3 (Menadione) as Auxiliary Therapy in Cancer Treatment
Medicinal Chemistry Reviews - Online (Discontinued) A Comprehensive Review on Combretastatin Analogues as Tubulin Binding Agents
Current Organic Chemistry Assessment of Retinal Structural and Functional Characteristics in Eyes with Autoimmune Retinopathy
Current Molecular Medicine Proteome Analysis of Formalin-Fixed Paraffin-Embedded Tissues from a Primary Gastric Melanoma and its Meningeal Metastasis: A Case Report
Current Topics in Medicinal Chemistry Oestrogen-A Protective Factor in Schizophrenia?
Current Psychiatry Reviews Natural Products Based Anticancer Agents
Mini-Reviews in Organic Chemistry Pharmacokinetics-Pharmacology Disconnection of Herbal Medicines and its Potential Solutions with Cellular Pharmacokinetic-Pharmacodynamic Strategy
Current Drug Metabolism Meditation: A Review of its Use in Western Medicine and, in Particular, its Role in the Management of Sexual Dysfunction
Current Psychiatry Reviews Hemangiomas, Angiosarcomas, and Vascular Malformations Represent the Signaling Abnormalities of Pathogenic Angiogenesis
Current Molecular Medicine HDAC Inhibitor Sodium Butyrate Augments the MEF2C Enhancement of Nampt Expression under Hypoxia
Current Pharmaceutical Design The Influenza Virus NS1 Protein: Inhibitor of Innate and Adaptive Immunity
Infectious Disorders - Drug Targets RNA Interference in Cancer: Targeting the Anti-Apoptotic Protein c-FLIP for Drug Discovery
Mini-Reviews in Medicinal Chemistry Management of Chemotherapy Induced Cardiomyopathy
Current Cardiology Reviews Soluble Adhesion Molecules in the Pathogenesis of Rheumatoid Arthritis
Current Pharmaceutical Design Long-Term Safety from the Raltegravir Clinical Development Program
Current HIV Research Design and Structure of Peptide and Peptidomimetic Antagonists of Protein- Protein Interaction
Current Protein & Peptide Science Celecoxib A Selective COX-2 Inhibitor Mitigates Fibrosis but not Pneumonitis Following Lung Irradiation: A Histopathological Study
Current Drug Therapy Molecular Fundamentals and Rationale for Immunotherapy in Metastatic Melanoma Treatment
Clinical Cancer Drugs Tetraspanins - Gateways for Infection
Infectious Disorders - Drug Targets Cancer-Associated Carbonic Anhydrases and Their Inhibition
Current Pharmaceutical Design